TBC: with stronger defenses molecules

(ANSAmed) – MILAN, 20 JUN – discovered a new class of molecules capable of strengthening the response of the immune system to the tuberculosis pathogen. Researchers at the National Institute of health and the National Institute of infectious diseases Spallanzani have developed an adjuvant vaccine against Mycobacterium tuberculosis. The strategy used is one that is based on Autophagy, a process in which the infected cells are induced by specific molecules to devour themselves. All rights reserved